UOC
AMPE

UBS O'Connor’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

UBS O'Connor’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-250
Closed -$476K – 569
2014
Q1 		$476K Buy
+250
New +$591K 0.01% 358

Other funds holding AMPE

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
TC
Talkot Capital Sausalito, California $73.7M AUM 8.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

UBS O'Connor's AMPE Position: Q2 2014 in Review

UBS O'Connor sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2014, closing a stake of 250 shares — an estimated $476K sold.

UBS O'Connor first reported a position in AMPE in Q1 2014 and held it in 1 quarter. The position peaked at $476K in Q1 2014. 75 funds tracked by Wall St. Rank hold AMPE as of Q2 2014.

  • UBS O'Connor reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2014 after selling out during the quarter.
  • UBS O'Connor sold 250 Ampio Pharmaceuticals Inc. shares in Q2 2014, an estimated $476K.
  • UBS O'Connor first reported a position in Ampio Pharmaceuticals Inc. in Q1 2014 and held it in 1 quarter.
  • UBS O'Connor's Ampio Pharmaceuticals Inc. position peaked at $476K in Q1 2014.
  • 75 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2014.

Based on UBS O'Connor's 13F filing for Q2 2014, filed 15 Aug 2014.